Mozifor Injection (Plerixafor): Uses, Benefits, Side Effects and Product Information

Mozifor Injection is a prescription medicine containing plerixafor, used in stem cell mobilization for eligible patients undergoing autologous stem cell transplantation. It helps move blood-forming stem cells from the bone marrow into the bloodstream, allowing healthcare professionals to collect these cells for transplantation. Product listings identify Mozifor as a plerixafor injection in a 24 mg/1.2 mL presentation; confirm the exact product specifications before publication.

For healthcare professionals, hospitals, oncology centres and pharmaceutical procurement teams, understanding Mozifor Injection’s composition, therapeutic role, safety profile and storage requirements is essential. Cordium Pharmaceuticals Pvt. Ltd. provides pharmaceutical product information to support informed enquiries and responsible procurement.

Product Description of Mozifor Injection

Mozifor Injection contains plerixafor, a hematopoietic stem cell mobilizer. It works by blocking the CXCR4 receptor, helping release blood-forming stem cells from the bone marrow into the peripheral blood.

Plerixafor is used with granulocyte colony-stimulating factor (G-CSF), such as filgrastim, for stem cell collection in eligible patients with multiple myeloma or non-Hodgkin lymphoma. Treatment must follow the applicable prescribing information and specialist supervision.

Product details

Brand name: Mozifor Injection

Active ingredient: Plerixafor

Reported presentation: 24 mg/1.2 mL

Therapeutic category: Hematopoietic stem cell mobilizer

Administration: Subcutaneous injection by a qualified healthcare professional

Use: Stem cell mobilization for collection and subsequent autologous transplantation in eligible patients

Uses and Potential Benefits of Mozifor Injection

1. Supports stem cell collection

Mozifor Injection helps increase the number of blood-forming stem cells circulating in the bloodstream, making them available for collection through a procedure called apheresis.

2. Supports autologous stem cell transplantation

Collected stem cells can be stored and subsequently returned to the patient as part of an autologous stem cell transplant treatment plan.

3. Helps mobilize hematopoietic stem cells

Plerixafor works through the CXCR4 pathway, supporting stem cell mobilization when prescribed alongside an appropriate G-CSF regimen.

4. Supports specialist-led oncology treatment

For selected patients with multiple myeloma or non-Hodgkin lymphoma, plerixafor may form part of a specialist-designed stem cell collection strategy.

Treatment suitability and outcomes vary by patient. Mozifor Injection is not a standalone cure for cancer.

Side Effects of Mozifor Injection

Like other prescription medicines, Mozifor Injection may cause adverse reactions. Commonly reported side effects of plerixafor include:

Nausea and vomiting

Diarrhoea

Fatigue or weakness

Headache

Dizziness

Joint pain

Redness, swelling or discomfort at the injection site

Serious safety concerns: Severe allergic reactions, changes in white blood cell or platelet counts, and enlargement or rupture of the spleen have been reported. Seek immediate medical attention for breathing difficulty, facial or throat swelling, or severe left upper abdominal or left shoulder pain.

Patients should inform their healthcare team about kidney problems, pregnancy, breastfeeding, allergies and all medicines being taken. Blood counts and other relevant clinical parameters may require monitoring. The medicine should only be administered under medical supervision.

Frequently Asked Questions (FAQs)

1. What is Mozifor Injection used for?

Mozifor Injection contains plerixafor and is used with G-CSF to mobilize blood-forming stem cells for collection and subsequent autologous transplantation in eligible patients.

2. What is the active ingredient in Mozifor Injection?

The reported active ingredient is plerixafor. Confirm the formulation and strength against the product label before use or procurement.

3. How does Mozifor Injection work?

Plerixafor blocks the CXCR4 receptor, helping stem cells move from the bone marrow into the bloodstream for collection.

4. What are the common side effects?

Common side effects include nausea, diarrhoea, vomiting, fatigue, headache, dizziness, joint pain and injection-site reactions.

5. Can Mozifor Injection be self-administered?

No. It should be administered by a qualified healthcare professional according to the prescribed treatment schedule.

6. Where can healthcare professionals enquire about Mozifor Injection?

Healthcare professionals and eligible pharmaceutical procurement teams can contact Cordium Pharmaceuticals Pvt. Ltd. to enquire about product availability, documentation and applicable supply requirements.

Contact Cordium Pharmaceuticals Pvt. Ltd.

For product-related enquiries, contact Cordium Pharmaceuticals Pvt. Ltd. to discuss pharmaceutical supply requirements and the documentation applicable to your market.